This document outlines the evaluation process that WHO undertakes to assess novel tools and strategies targeted at VBDs. Its aim is to articulate the linkage between the generation of evidence that demonstrates public health impact of novel interventions, and the development of policy recommendation...s based on the generated data. The document defines standards for the evaluation process, as well as the steps that an applicant needs to undertake, along with some guiding principles that aim to support applicants in the development of submissions with WHO.
more
The aim of this publication is to provide practical guidance for the first responders who will respond during the first few hours to a radiological emergency and for the national officials who would support this early response. This publication provides guidance in the form of action guides, instruc...tions and data that can be easily applied by a State to build a basic capability to respond to a radiological emergency.
Also available in Arabic, French, Russian and Spanish: https://www-pub.iaea.org/books/IAEABooks/7606/Manual-for-First-Responders-to-a-Radiological-Emergency
more
Section I
Somatoform disorders
Child Psychiatry and Pediatrics
Chapter I.1
BMJ Open Science 2021;5:e100202. doi:10.1136/
bmjos-2021-100202
This publication is an updated version of the Management of Tuberculosis and HIV Coinfection clinical protocol released in 2007 by the WHO Regional Office for Europe. It is intended for all health care workers involved in preventing, diagnosing, treating and caring for people living with TB and HIV ...in the specific settings of the WHO European Region.
more
A short Guide for Health Practitioners
MOH Policy and Guidelines for Health Institutions
A tool for measuring alcohol policy implementation
This study looked at structural risk factors to COVID-19 that existed before the outbreak and may have direct and indirect effects on COVID-19 risk across all the 47 counties in Kenya. These factors are COVID-19 exposure and vulnerability and lack of adaptive capacity to COVID-19.